EPLR 2/2021 Out Now
The second issue of the European Pharmaceutical Law Review in 2021 is now available. The issue features the following articles, reports and case notes:
- 'No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19
- Pharmaceutical Advertising in Digital Media: A Danish Perspectiv
- Sponsoring a Clinical Trial: Pharmaceutical Companies’ Liability under the Scrutiny of the Italian Supreme Court
- Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization?
View the whole table of content of EPLR 2/2021: Here
Become an Author for EPLR and view our Call for Papers